NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

8225	Companies
111035	Keywords
52757	Articles
60941	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 06/02/2024 at 16:00, 5 months 5 days ago

Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy
Nanobiotix announces new data from Study 1100 showing disease control and tumor response in patients with R/M HNSCC treated with RT-activated NBTXR3 followed by anti-PD-1. Investor event scheduled on June 2nd

NANOBIOTIX Study 1100 R/M HNSCC RT-activated NBTXR3 Anti-PD-1
BRIEF

published on 05/28/2024 at 22:20, 5 months 10 days ago

NANOBIOTIX Présente de Nouvelles Données à l'ASCO 2024

Immunothérapie NANOBIOTIX NBTXR3 ASCO Phase 1
BRIEF

published on 05/28/2024 at 22:20, 5 months 10 days ago

NANOBIOTIX Presents New Data at ASCO 2024

Immunotherapy NANOBIOTIX NBTXR3 ASCO Phase 1
PRESS RELEASE

published on 05/28/2024 at 22:15, 5 months 10 days ago

NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call
Nanobiotix to present new data from Phase 1 immunotherapy program at 2024 ASCO meeting followed by investor conference call. Details for the call provided

Investor Conference Call Immunotherapy ASCO 2024 NANOBIOTIX Phase 1
PRESS RELEASE

published on 05/28/2024 at 22:15, 5 months 10 days ago

NANOBIOTIX annonce une présentation de nouvelles données et du programme d’immunothérapie de Phase 1 lors de la réunion annuelle 2024 de l’American Society for Clinical Oncology (ASCO) suivi d’une conférence téléphonique et webcast
Nanobiotix annonce la présentation de nouvelles données et du programme d'immunothérapie de phase 1 lors de la réunion annuelle 2024 de l'ASCO, suivi d'une conférence téléphonique et webcast

Immunothérapie Cancer ASCO 2024 NANOBIOTIX NBTXR3
BRIEF

published on 05/23/2024 at 22:20, 5 months 15 days ago

NANOBIOTIX fera une présentation à la conférence Jefferies Global Healthcare

Biotechnologie Webdiffusion Traitement Du Cancer NANOBIOTIX Conférence Mondiale Jefferies Sur Les Soins De Santé
BRIEF

published on 05/23/2024 at 22:20, 5 months 15 days ago

NANOBIOTIX to Present at the Jefferies Global Healthcare Conference

Biotechnology Cancer Treatment Webcast NANOBIOTIX Jefferies Global Healthcare Conference
PRESS RELEASE

published on 05/23/2024 at 22:15, 5 months 15 days ago

NANOBIOTIX participera à la conférence Jefferies Global Healthcare
Nanobiotix participera à la conférence Jefferies Global Healthcare pour discuter de ses avancées en biotechnologie. Détails de l'événement et webcast disponibles

Biotechnologie Traitement Cancer NANOBIOTIX Conférence Jefferies
PRESS RELEASE

published on 05/23/2024 at 22:15, 5 months 15 days ago

NANOBIOTIX to Present at the Jefferies Global Healthcare Conference
Nanobiotix to present at the Jefferies Global Healthcare Conference on June 5, 2024, with Bart Van Rhijn, CFO, participating in a fireside chat. Company pioneering physics-based approaches for cancer treatment

Cancer Treatment Biotechnology Company NANOBIOTIX Jefferies Global Healthcare Conference Physics-based Approaches
BRIEF

published on 05/21/2024 at 22:20, 5 months 17 days ago

Nanobiotix annonce des progrès dans le développement de NBTXR3 et une collaboration stratégique

Biotechnologie Thérapie Contre Le Cancer NANOBIOTIX NBTXR3 Collaboration Janssen

Accesswire

Published on 11/08/2024 at 12:00, 21 minutes ago

Fusion Energy Agreement Between RSE and BLUE LASER FUSION (USA)
Published on 11/08/2024 at 10:00, 2 hours 21 minutes ago

BluSky Carbon CEO Presents a Case for Climate Tech Optimism
Published on 11/08/2024 at 09:00, 3 hours 21 minutes ago

Greene Tweed Awarded 'Excellence in International Trade' at the 2024 East Midlands Chamber Business Awards
Published on 11/08/2024 at 07:00, 5 hours 21 minutes ago

Polaris Renewable Energy Announces Fixed Income Meetings
Published on 11/08/2024 at 03:00, 9 hours 21 minutes ago

Alset AI Appoints Wall Street Veteran and Venture Executive as President

View all ACCESSWIRE

EQS Group

Published on 11/08/2024 at 12:11, 10 minutes ago

PNE AG selected by the European Commission for funding a project to produce hydrogen
Published on 11/08/2024 at 12:01, 20 minutes ago

EQS-Adhoc: Borussia Dortmund reports preliminary figures for the first quarter (Q1) of the 2024/2025 financial year
Published on 11/08/2024 at 12:01, 20 minutes ago

Original-Research: Knaus Tabbert AG (von Montega AG): Kaufen
Published on 11/08/2024 at 11:30, 51 minutes ago

Shelly Group: Invitation to unaudited 9M 2024 earnings webcast/call on 14 November 2024
Published on 11/08/2024 at 11:12, 1 hour 9 minutes ago

Original-Research: Masterflex SE (von Montega AG): Kaufen

Les Echos

Published on 11/08/2024 at 12:15, 6 minutes ago

Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 6 minutes ago

Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 08:00, 4 hours 21 minutes ago

DAMARTEX / Droits de vote bruts et réels 31 octobre 2024
Published on 11/07/2024 at 19:00, 17 hours 21 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/07/2024 at 19:00, 17 hours 21 minutes ago

ALTAREA : DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR LA SOCIETE SUR SES PROPRES TITRES OCTOBRE 2024

View all LES ECHOS COMFI WIRE